Saptarshi Mukherjee

Saptarshi Mukherjee

Auto-generated profile, based on publicly available information

Saptarshi Mukherjee

Department of Naturopathy, Saffron Research Institute, India

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 April 2024
Verified
Conference Paper
Closed access
KYKottala Sri Yogi
Kottala Sri Yogi
VGV Dankan Gowda
V Dankan Gowda
DSD Sindhu
D Sindhu
HSHariprasad Soni
Hariprasad Soni
SMSaptarshi Mukherjee
Saptarshi Mukherjee
GMG.C Madhu
G.C Madhu
In the general scope of social media analytics, sentiment analysis is one of the most significant tools that can be employed to elucidate useful information from a vast amount of textual data. However, one of the primary problems that still persist with sentiment analysis is its accuracy because it is hard to understand precisely what a person meant on the vastness of the Web. In this research, these machine learning algorithms such as Naive Bayes (NB), Support Vector Machines and others are compared to determine its efficiency in enhancing the rate of accuracy in sentiment analysis across social media. Through data collection from various social media sources, which are preceded by stringent pre-processing techniques such as text normalization and feature extraction the performance of each model is evaluated. However, the findings present significant disparities in these models’ accuracies, illustrating their best conditions of operation. This research helps to fill the gap in literature by offering a more subtle idea of strengths and weaknesses of every machine learning methodology when used for sentiment analysis applications, which is useful information on how researchers as well as practitioners can improve analytical accuracy within social media context.

16 January 2026 in Smart Wearable Technology
Verified
Journal Article
Open access
PDF file
SHSai Han Htun
Sai Han Htun
IMIqra Mumtaz
Iqra Mumtaz
UAUmaira Abbasi
Umaira Abbasi
MKMarriyum Rashid Khan
Marriyum Rashid Khan
SMSaptarshi Mukherjee
Saptarshi Mukherjee
FBFadila Shuaibu Bello
Fadila Shuaibu Bello
Nanorobots are nanoscale devices engineered to perform precise diagnostic or therapeutic tasks in the body. This narrative review synthesizes advances in nanorobot design (materials, propulsion, navigation, and communication) and highlights applications in drug delivery, imaging/diagnostics, surgery, and immune system modulation. We searched PubMed and Google Scholar using keywords “nanorobots,” “nanorobotics,” “drug delivery,” “diagnostics,” and “theranostics,” including peer-reviewed English original research and review articles and excluding non-peer-reviewed. In drug delivery, targeted nanocarriers have enabled precise chemotherapy delivery; a stimulus-responsive DNA-origami nanobot delivered ligands to cluster death receptors on breast cancer cells, yielding ~70% tumor reduction in a mouse model. Other designs use magnetic or chemical propulsion to traverse barriers (e.g., blood–brain barrier) and release drugs via triggers (pH, temperature, enzymes). In imaging/diagnostics, magnetically actuated nanorobots carrying radiopaque materials (barium sulfate/magnetite) have been navigated for micro-Computed Tomography tracking of gastrointestinal targets, and sensor-equipped nanobots can detect tumor biomarkers and relay signals for early disease detection. In microsurgery, remotely controlled microdrills and soft robots enable minimally invasive procedures such as plaque removal and targeted thrombectomy. Nanorobots can also modulate immunity: polymeric nanocarriers deliver immunosuppressants to inflamed tissue, and artificial antigen-presenting nanobots expand regulatory T cell populations in vivo. These advances demonstrate high-precision capabilities, but findings remain largely preclinical, and we have tempered language about “imminent” translation. Clinical readiness requires overcoming biocompatibility, powering, manufacturability, and safety hurdles; regulatory classification is unclear, and many may be high-risk (Class III) devices requiring full premarket approval. Ethical and societal issues (patient autonomy, data privacy, long-term persistence, equitable access) also demand attention, while bio-hybrid designs (cell-membrane coatings, living cell robots) seek to mitigate immune clearance. Conclusion: nanorobots hold transformative potential for personalized medicine, but cautious optimism is warranted. Received: 2 September 2025 | Revised: 8 December 2025 | Accepted: 31 December 2025 Conflicts of Interest The authors declare that they have no conflicts of interest to this work. Data Availability Statement Data are available from the corresponding author upon reasonable request. Author Contribution Statement Sai Han Htun: Conceptualization, Methodology, Validation, Resources, Data curation, Writing – original draft, Writing – review & editing, Visualization, Supervision, Project administration. Iqra Mumtaz: Conceptualization, Validation, Resources, Data curation, Writing – original draft. Umaira Abbasi: Methodology, Resources, Writing – original draft. Marriyum Rashid Khan: Conceptualization, Resources, Writing – original draft. Saptarshi Mukherjee: Resources, Writing – original draft, Visualization, Supervision. Arun Kumar Maloth: Conceptualization, Resources, Writing – original draft. Fadila shuaibu Bello: Resources, Writing – original draft.

5 April 2024
Verified
Book Chapter
Closed access
VGV. Dankan Gowda
V. Dankan Gowda
SMSaptarshi Mukherjee
Saptarshi Mukherjee
SSSajja Suneel
Sajja Suneel
DADinesh Arora
Dinesh Arora
UKUjjwal Kumar Kamila
Ujjwal Kumar Kamila
In recent years, the application of machine learning techniques has brought about a profound transformation in the field of bioinformatics. This chapter is dedicated to examining the latest developments in both bioinformatics and machine learning while also exploring potential future directions. Within these pages, the authors delve into the potential advantages of employing machine learning to enhance critical bioinformatics tasks, such as the analysis of genomic sequences and the prediction of protein structures through modeling. The chapter also addresses the challenges faced by researchers when integrating these diverse fields. Nevertheless, optimism prevails in the realm of bioinformatics research, driven by the ever-expanding wealth of biological data and the potential for the development of more sophisticated machine learning models. Request access from your librarian to read this chapter's full text.